109 related articles for article (PubMed ID: 7935035)
1. A case of diabetes following tibolone therapy.
Konstantopoulos K; Adamides S
Maturitas; 1994 May; 19(1):77-8. PubMed ID: 7935035
[No Abstract] [Full Text] [Related]
2. Is Livial diabetogenic?
Atsma WJ
Maturitas; 1994 Oct; 19(3):239-40. PubMed ID: 7799830
[No Abstract] [Full Text] [Related]
3. [Our experience in the treatment of climacteric complaints with Livial (Organon)].
Pekhlivanov B; Malinova M; Milchev N
Akush Ginekol (Sofiia); 2001; 40(4):16-7. PubMed ID: 11803863
[TBL] [Abstract][Full Text] [Related]
4. Prevention of post-oophorectomy bone loss with Tibolone.
Lyritis GP; Karpathios S; Basdekis K; Grigoriou O; Katostaras T; Paspati I; Stamatopoulos T; Siampalioti G; Lyritis PG
Maturitas; 1995 Nov; 22(3):247-53. PubMed ID: 8746883
[TBL] [Abstract][Full Text] [Related]
5. Effect of tibolone on postmenopausal women with myomas.
Gregoriou O; Vitoratos N; Papadias C; Konidaris S; Costomenos D; Chryssikopoulos A
Maturitas; 1997 Jun; 27(2):187-91. PubMed ID: 9255754
[TBL] [Abstract][Full Text] [Related]
6. Changes in sex behaviour after menopause: effects of tibolone.
Palacios S; Menendez C; Jurado AR; Castaño R; Vargas JC
Maturitas; 1995 Sep; 22(2):155-61. PubMed ID: 8538485
[TBL] [Abstract][Full Text] [Related]
7. Effects of tibolone on lipoprotein(a) and HDL subfractions.
Farish E; Barnes JF; Rolton HA; Spowart K; Fletcher CD; Hart DM
Maturitas; 1994 Dec; 20(2-3):215-9. PubMed ID: 7715475
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of two hormone replacement therapy regimens on safety and efficacy variables.
Siseles NO; Halperin H; Benencia HJ; Berg G; Pilnik S; Mesch V; Arrighi B; Wikinski RW
Maturitas; 1995 Apr; 21(3):201-10. PubMed ID: 7616869
[TBL] [Abstract][Full Text] [Related]
9. Effect on sexual life--a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen.
Nathorst-Böös J; Hammar M
Maturitas; 1997 Jan; 26(1):15-20. PubMed ID: 9032742
[TBL] [Abstract][Full Text] [Related]
10. Vaginal ultrasound of the endometrium in postmenopausal women with symptoms of urogenital atrophy on low-dose estrogen or tibolone treatment: a comparison.
Botsis D; Kassanos D; Kalogirou D; Antoniou G; Vitoratos N; Karakitsos P
Maturitas; 1997 Jan; 26(1):57-62. PubMed ID: 9032748
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
Hudita D; Posea C; Ceausu I; Rusu M
Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
[TBL] [Abstract][Full Text] [Related]
12. [Tibolone--a new steroid for therapy of the climacteric syndrome and prevention of osteoporosis].
Presl J
Cesk Gynekol; 1991 May; 56(4):299-301. PubMed ID: 1913870
[No Abstract] [Full Text] [Related]
13. Economic impact of tibolone compared with continuous-combined hormone replacement therapy. In the management of postmenopausal women with climacteric symptoms in the UK.
Plumb JM; Guest JF
Pharmacoeconomics; 2000 Nov; 18(5):477-86. PubMed ID: 11151401
[TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of tibolone in postmenopausal women with non-insulin dependent diabetes mellitus.
Prelevic GM; Beljic T; Balint-Peric L; Ginsburg J
Maturitas; 1998 Jan; 28(3):271-6. PubMed ID: 9571604
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor (IGF)-I levels in postmenopausal women receiving tibolone.
Hopkins KD; Parker JR; Lehmann ED; Rymer J; Holly JM; Fogelman I; Cwyfan-Hughes S; Teale JD; Gosling RG
Horm Metab Res; 1995 Aug; 27(8):387-8. PubMed ID: 7590630
[No Abstract] [Full Text] [Related]
16. Carcinoma of the endometrium in patients treated with tibolone.
Yazigi R; Sahid S; Contreras L; Rodriguez T
Gynecol Oncol; 2004 May; 93(2):568-70. PubMed ID: 15099984
[TBL] [Abstract][Full Text] [Related]
17. Tibolone: new type of hormone replacement.
Harv Womens Health Watch; 2001 Dec; 9(5):5. PubMed ID: 11751099
[No Abstract] [Full Text] [Related]
18. Cognitive effects of 10 years of hormone-replacement therapy with tibolone.
Fluck E; File SE; Rymer J
J Clin Psychopharmacol; 2002 Feb; 22(1):62-7. PubMed ID: 11799344
[TBL] [Abstract][Full Text] [Related]
19. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome.
Di Carlo C; Palomba S; Tommaselli GA; Guida M; Di Spiezio Sardo A; Nappi C
Fertil Steril; 2001 Feb; 75(2):380-4. PubMed ID: 11172843
[TBL] [Abstract][Full Text] [Related]
20. [The concept of selective action steroids].
Jamin C
Gynecol Obstet Fertil; 2000 Dec; 28(12):931-9. PubMed ID: 11192203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
